As on Wednesday, Lucid Diagnostics Inc (NASDAQ: LUCD) got off with the flyer as it spiked 5.31% to $1.19, before settling in for the price of $1.13 at the close. Taking a more long-term approach, LUCD posted a 52-week range of $0.80-$1.80.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -54.43%. Meanwhile, its Annual Earning per share during the time was -54.43%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 38.48%. This publicly-traded company’s shares outstanding now amounts to $130.92 million, simultaneously with a float of $94.16 million. The organization now has a market capitalization sitting at $156.01 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1025, while the 200-day Moving Average is $1.1766.
Lucid Diagnostics Inc (LUCD) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Lucid Diagnostics Inc’s current insider ownership accounts for 28.17%, in contrast to 27.77% institutional ownership. According to the most recent insider trade that took place on Aug 20 ’25, this organization’s Director bought 100,000 shares at the rate of 1.02, making the entire transaction reach 101,840 in total value, affecting insider ownership by 665,443. Preceding that transaction, on May 20 ’25, Company’s Director bought 187,098 for 1.29, making the whole transaction’s value amount to 242,292. This particular insider is now the holder of 187,098 in total.
Lucid Diagnostics Inc (LUCD) Earnings and Revenue Records
Lucid Diagnostics Inc’s EPS increase for this current 12-month fiscal period is 38.48% and is forecasted to reach -0.30 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 31.40% through the next 5 years, which can be compared against the -54.43% growth it accomplished over the previous five years trading on the market.
Lucid Diagnostics Inc (NASDAQ: LUCD) Trading Performance Indicators
Let’s observe the current performance indicators for Lucid Diagnostics Inc (LUCD). It’s Quick Ratio in the last reported quarter now stands at 1.87. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 35.46.
In the same vein, LUCD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.90, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.30 at the market close of one year from today.
Technical Analysis of Lucid Diagnostics Inc (LUCD)
Through scrutinizing the latest numbers posted by the [Lucid Diagnostics Inc, LUCD], it can be observed that its last 5-days Average volume of 0.57 million was better the volume of 0.55 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 88.41% While, its Average True Range was 70.21.
Raw Stochastic average of Lucid Diagnostics Inc (LUCD) in the period of the previous 100 days is set at 37.52%, which indicates a major fall in contrast to 100.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0414 that was lower than 0.0597 volatility it exhibited in the past 100-days period.
